Mathieu Ferrari
Impact in
-
- Rheumatoid Arthritis Research and Therapies
Papers in
-
- Monoclonal and Polyclonal Antibodies Research 11
- Oncology 11
- CAR-T cell therapy research 6
- HER2/EGFR in Cancer Research 3
- Co-authors
- Shimobi Onuoha (15 shared papers)Costantino Pitzalis (8 shared papers)Daniele Sblattero (5 shared papers)Martin Pulé (12 shared papers)M. Taraborelli (2 shared papers)Laura Andréoli (2 shared papers)Silvana Archetti (2 shared papers)Anǵela Tincani (1 shared paper)
- Journals
- Annals of the Rheumatic Diseases (3 papers)Blood (2 papers)Frontiers in Immunology (2 papers)Cancer Research (2 papers)ACS Chemical Biology (1 paper)
- Partner nations
- United KingdomItalyUnited States
In The Last Decade
Mathieu Ferrari
26 papers receiving 286 citations
Peers
Comparison fields: 5 of 60
- Rheumatology 65
- Immunology 72
- Radiology, Nuclear Medicine and Imaging 72
- Oncology 60
- Genetics 23
Countries citing papers authored by Mathieu Ferrari
This map shows the geographic impact of Mathieu Ferrari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mathieu Ferrari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mathieu Ferrari more than expected).
Fields of papers citing papers by Mathieu Ferrari
This network shows the impact of papers produced by Mathieu Ferrari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mathieu Ferrari. The network helps show where Mathieu Ferrari may publish in the future.
Co-authors
The 25 scholars most cited alongside Mathieu Ferrari, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 54 | |
| 2 | 2014 | 29 | |
| 3 | Methylenetetrahydrofolate reductase polymorphisms and methotrexate: no association with response to therapy nor with drug-related adverse events in an Italian population of rheumatic patients. | 2009 | 27 |
| 4 | 2021 | 25 | |
| 5 | 2024 | 20 | |
| 6 | 2015 | 19 | |
| 7 | 2020 | 17 | |
| 8 | 2021 | 13 | |
| 9 | 2011 | 13 | |
| 10 | 2015 | 13 | |
| 11 | 2021 | 11 | |
| 12 | 2018 | 8 | |
| 13 | BAEP and E.M.G. changes from whiplash injuries. | 1994 | 8 |
| 14 | 2021 | 7 | |
| 15 | 2020 | 6 | |
| 16 | 2024 | 5 | |
| 17 | 2020 | 4 | |
| 18 | 2023 | 3 | |
| 19 | 2021 | 3 | |
| 20 | 2011 | 2 |
About Mathieu Ferrari
Mathieu Ferrari is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology, Molecular Biology, Immunology and Rheumatology, having authored 28 papers that have together received 294 indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (11 papers), CAR-T cell therapy research (6 papers), Rheumatoid Arthritis Research and Therapies (5 papers), SARS-CoV-2 and COVID-19 Research (3 papers), HER2/EGFR in Cancer Research (3 papers), SARS-CoV-2 detection and testing (3 papers), Glycosylation and Glycoproteins Research (2 papers) and Advanced Biosensing Techniques and Applications (2 papers). The work is most often cited by research in Rheumatology (65 citations), Immunology (72 citations), Radiology, Nuclear Medicine and Imaging (72 citations), Oncology (60 citations) and Genetics (23 citations). Mathieu Ferrari has collaborated with scholars based in United Kingdom, Italy and United States. Frequent co-authors include Shimobi Onuoha, Costantino Pitzalis, Daniele Sblattero, Martin Pulé, M. Taraborelli, Laura Andréoli, Silvana Archetti, Anǵela Tincani, Reyisa Bughda and James Sillibourne. Their work appears in journals such as Annals of the Rheumatic Diseases, Blood, Frontiers in Immunology, Cancer Research and ACS Chemical Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.